InsidersTradesSigma
Jiangsu Recbio Technology Co., Ltd. - B: management transactions · Hong Kong · HKEX
HKEX:jiangsu-recbio-technology-co-ltd-b-h-sharesHK·HKEXMcap 3.2Bn€Healthcare
Browse the full directors' dealings record of Jiangsu Recbio Technology Co., Ltd. - B, a listed equity based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Jiangsu Recbio Technology Co., Ltd. - B has published 5 insider filings. Market capitalisation: €3.2bn. The latest transaction was disclosed on 6 May 2026 — Sale. Among the most active insiders: Xu Haoyu. The full history is openly available.
5
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5.15 €
Analyst consensus
Income statement
Revenue12.7 M€
Gross profit11.2 M€88% margin
Net income−610.4 M€-4796.4% margin
Valuation
P/Book3.7x
Beta0.09
Balance sheet & cash
Market cap3.22 Bn€
Total debt638.5 M€
Free Cash Flow−601.5 M€
Debt / Equity90%
Profitability & ownership
ROE-98.8%
ROA-20.4%
% insiders46.4%
% institutions21.1%
Last declaration on 6 May 2026
Declarations5 total
5 of 5 declarations